{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T05:00:34Z","timestamp":1785042034851,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":64,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Science Research Project of Hebei","award":["20240905"],"award-info":[{"award-number":["20240905"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-54166-z","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:04:29Z","timestamp":1779293069000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["miR-542-3p targets TTF1 to regulate proliferation, invasion, and migration of lung adenocarcinoma via the MAPK signaling pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"Baoshan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqiao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"issue":"2","key":"54166_CR1","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jtcvs.2024.05.009","volume":"169","author":"CN Fick","year":"2025","unstructured":"Fick, C. N. et al. High-risk features associated with recurrence in stage I lung adenocarcinoma. J. Thorac. Cardiovasc. Surg. 169 (2), 436\u2013444e6 (2025).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"1","key":"54166_CR2","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.1038\/s41467-025-59623-3","volume":"16","author":"T Shinozaki","year":"2025","unstructured":"Shinozaki, T. et al. Basal-shift transformation leads to EGFR therapy-resistance in human lung adenocarcinoma. Nat. Commun. 16 (1), 4369 (2025).","journal-title":"Nat. Commun."},{"issue":"7","key":"54166_CR3","doi-asserted-by":"publisher","first-page":"e2414625","DOI":"10.1002\/advs.202414625","volume":"12","author":"Y Li","year":"2025","unstructured":"Li, Y., Chen, S., Rao, H., Cui, S. & Chen, G. MicroRNA Gets a Mighty Award. Adv. Sci. (Weinh). 12 (7), e2414625 (2025).","journal-title":"Adv. Sci. (Weinh)"},{"key":"54166_CR4","doi-asserted-by":"publisher","first-page":"114113","DOI":"10.1016\/j.addr.2022.114113","volume":"182","author":"G Kara","year":"2022","unstructured":"Kara, G., Calin, G. A. & Ozpolat, B. RNAi-based therapeutics and tumor targeted delivery in cancer. Adv. Drug Deliv Rev. 182, 114113 (2022).","journal-title":"Adv. Drug Deliv Rev."},{"issue":"1","key":"54166_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/0113892029298721240627095839","volume":"26","author":"Q Ren","year":"2025","unstructured":"Ren, Q. et al. Gene-knockdown Methods for Silencing Nuclear-localized Insulin Receptors in Lung Adenocarcinoma Cells: A Bioinformatics Approach. Curr. Genomics. 26 (1), 24\u201335 (2025).","journal-title":"Curr. Genomics"},{"issue":"1","key":"54166_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/0113892029277397231228062412","volume":"25","author":"M Li","year":"2024","unstructured":"Li, M. et al. A Novel Methylation-based Model for Prognostic Prediction in Lung Adenocarcinoma. Curr. Genomics. 25 (1), 26\u201340 (2024).","journal-title":"Curr. Genomics"},{"key":"54166_CR7","doi-asserted-by":"crossref","unstructured":"Zhu, X. et al. Identification and Validation of Amino Acid Metabolism-Related Biomarkers and Investigation of their Potential Mechanisms in Lung Adenocarcinoma. Curr Gene Ther. Published online April 18, 2025.","DOI":"10.2174\/0115665232364091250203090710"},{"issue":"2","key":"54166_CR8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2174\/0115665232286359240611051307","volume":"25","author":"XJ Wang","year":"2025","unstructured":"Wang, X. J., Huo, Y. X., Yang, P. J., Gao, J. & Hu, W. D. Significance of Ribonucleoside-diphosphate Reductase Subunit M2 in Lung Adenocarcinoma. Curr. Gene Ther. 25 (2), 136\u2013156 (2025).","journal-title":"Curr. Gene Ther."},{"issue":"1","key":"54166_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.canlet.2015.07.036","volume":"368","author":"T He","year":"2015","unstructured":"He, T. et al. Tumor cell-secreted angiogenin induces angiogenic activity of endothelial cells by suppressing miR-542-3p. Cancer Lett. 368 (1), 115\u2013125 (2015).","journal-title":"Cancer Lett."},{"issue":"Pt 1","key":"54166_CR10","doi-asserted-by":"publisher","first-page":"142252","DOI":"10.1016\/j.ijbiomac.2025.142252","volume":"308","author":"Y Qiu","year":"2025","unstructured":"Qiu, Y. et al. Ulvan derived from Ulva lactuca suppresses hepatocellular carcinoma cell proliferation through miR-542-3p-mediated downregulation of SLC35F6. Int. J. Biol. Macromol. 308 (Pt 1), 142252 (2025).","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"54166_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.bbrc.2016.04.093","volume":"474","author":"Z Rang","year":"2016","unstructured":"Rang, Z., Yang, G., Wang, Y. W. & Cui, F. miR-542-3p suppresses invasion and metastasis by targeting the proto-oncogene serine\/threonine protein kinase, PIM1, in melanoma. Biochem. Biophys. Res. Commun. 474 (2), 315\u2013320 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"54166_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s12032-014-0361-5","volume":"32","author":"X Shen","year":"2015","unstructured":"Shen, X. et al. MicroRNA-542-3p suppresses cell growth of gastric cancer cells via targeting oncogene astrocyte-elevated gene-1. Med. Oncol. 32 (1), 361 (2015).","journal-title":"Med. Oncol."},{"issue":"7","key":"54166_CR13","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1111\/cas.13271","volume":"108","author":"S Griesing","year":"2017","unstructured":"Griesing, S. et al. Takahashi T.TTF-l-regulated miR\u00b7 532-5p targets KRAS and MKL2 oncogenes and induces apoptosis in lung adenocarcinoma cells[J]. Cancer Sci. 108 (7), 1394\u20131404 (2017).","journal-title":"Cancer Sci."},{"key":"54166_CR14","doi-asserted-by":"crossref","unstructured":"Sachsenberg, N. et al. Turnover of CD4\u2009+\u2009and CD8\u2009+\u2009T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen[J]. J Exp Med,2018.26(8):1295\u20131300 (1998).","DOI":"10.1084\/jem.187.8.1295"},{"issue":"1","key":"54166_CR15","first-page":"7","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel, R. L. & MillerKD,Jemal, A. C. statistics,2018[J].CACancer. J. Clin. 68 (1), 7\u201330 (2018).","journal-title":"J. Clin."},{"issue":"19","key":"54166_CR16","doi-asserted-by":"publisher","first-page":"14614","DOI":"10.3390\/ijms241914614","volume":"24","author":"X Wei","year":"2023","unstructured":"Wei, X., Li, X., Hu, S., Cheng, J. & Cai, R. Regulation of Ferroptosis in Lung Adenocarcinoma. Int. J. Mol. Sci. 24 (19), 14614 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"33","key":"54166_CR17","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.2217\/fon-2019-0349","volume":"15","author":"S Rossi","year":"2019","unstructured":"Rossi, S. et al. Survival outcome of tyrosine kinase inhibitors beyond pn^ression in association to radiotherapy in oligoprogressive EGFR- mutant non-small-cell lung cancer[J]. Future Oncol. 15 (33), 3775\u20133782 (2019).","journal-title":"Future Oncol."},{"key":"54166_CR18","doi-asserted-by":"publisher","first-page":"107299","DOI":"10.1016\/j.phrs.2024.107299","volume":"206","author":"J Li","year":"2024","unstructured":"Li, J., Zhang, Y., Fu, T., Xing, G. & Tong, Y. Advancing cancer therapy: The role of MicroRNA in clinical applications[J]. Pharmacol. Res. 206, 107299 (2024).","journal-title":"Pharmacol. Res."},{"issue":"22","key":"54166_CR19","doi-asserted-by":"publisher","first-page":"13822","DOI":"10.3390\/ijms232213822","volume":"23","author":"K Kousar","year":"2022","unstructured":"Kousar, K. et al. miRNAs in Regulation of Tumor Microenvironment,Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer[J]. Int. J. Mol. Sci. 23 (22), 13822 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"54166_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole, R. & Slack, F. J. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat. Rev. Drug Discov. 16 (3), 203\u2013222 (2017).","journal-title":"Nat. Rev. Drug Discov"},{"issue":"9","key":"54166_CR21","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.3390\/ijms22094997","volume":"22","author":"A Sorop","year":"2021","unstructured":"Sorop, A. et al. Exosomal microRNAs as Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma[J]. Int. J. Mol. Sci. 22 (9), 4997 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"54166_CR22","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1007\/s12072-024-10722-1","volume":"18","author":"M Ismail","year":"2024","unstructured":"Ismail, M. et al. Dynamic role of exosomal long non-coding RNA in liver diseases: pathogenesis and diagnostic aspects[J]. Hepatol. Int. 18 (6), 1715\u20131730 (2024).","journal-title":"Hepatol. Int."},{"issue":"1","key":"54166_CR23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12943-024-02038-3","volume":"23","author":"M Wang","year":"2024","unstructured":"Wang, M. et al. Circ6834 suppresses non-small cell lung cancer progression by destabilizing ANHAK and regulating miR-873-5p\/TXNIP axis[J]. Mol. Cancer. 23 (1), 128 (2024).","journal-title":"Mol. Cancer"},{"key":"54166_CR24","doi-asserted-by":"publisher","first-page":"155601","DOI":"10.1016\/j.prp.2024.155601","volume":"263","author":"RQD Silvia Lima","year":"2024","unstructured":"Silvia Lima, R. Q. D. et al. miRNA-21, an oncomiR that regulates cell proliferation, migration, invasion and therapy response in lung cancer[J]. Pathol. Res. Pract. 263, 155601 (2024).","journal-title":"Pathol. Res. Pract."},{"issue":"8","key":"54166_CR25","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/s41416-024-02831-3","volume":"131","author":"M Abdipourbozorgbaghi","year":"2024","unstructured":"Abdipourbozorgbaghi, M., Vancura, A., Radpour, R. & Haefliger, S. Circulating miRNA panels as a novel non-invasive diagnostic, prognostic, and potential predictive biomarkers in non-small cell lung cancer (NSCLC)[J]. Br. J. Cancer. 131 (8), 1350\u20131362 (2024).","journal-title":"Br. J. Cancer"},{"key":"54166_CR26","doi-asserted-by":"publisher","first-page":"154724","DOI":"10.1016\/j.prp.2023.154724","volume":"248","author":"SH Alshahrani","year":"2023","unstructured":"Alshahrani, S. H. et al. The mechanisms, functions and clinical applications of miR-542-3p in human cancers[J]. Pathol. Res. Pract. 248, 154724 (2023).","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"54166_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12935-020-01168-0","volume":"20","author":"C Li","year":"2020","unstructured":"Li, C., Tian, Y., Liang, Y. & Li, Q. Circ_0008035 contributes to cell proliferation and inhibits apoptosis and ferroptosis in gastric cancer via miR-599\/EIF4A1 axis[J]. Cancer Cell. Int. 20 (1), 84 (2020).","journal-title":"Cancer Cell. Int."},{"issue":"Pt 1","key":"54166_CR28","doi-asserted-by":"publisher","first-page":"142252","DOI":"10.1016\/j.ijbiomac.2025.142252","volume":"308","author":"Y Qiu","year":"2025","unstructured":"Qiu, Y. et al. Ulvan derived from Ulva lactuca suppresses hepatocellular carcinoma cell proliferation through miR-542-3p-mediated downregulation of SLC35F6[J]. Int. J. Biol. Macromol. 308 (Pt 1), 142252 (2025).","journal-title":"Int. J. Biol. Macromol."},{"key":"54166_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.canlet.2018.01.065","volume":"420","author":"H Lyu","year":"2018","unstructured":"Lyu, H. et al. Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer[J]. Cancer Lett. 420, 97\u2013108 (2018).","journal-title":"Cancer Lett."},{"key":"54166_CR30","doi-asserted-by":"publisher","first-page":"6081","DOI":"10.2147\/OTT.S170482","volume":"11","author":"C Chen","year":"2018","unstructured":"Chen, C., Zhang, Z., Li, J. & Sun, Y. SNHG8 is identified as a key regulator in non-small-cell lung cancer progression sponging to miR-542-3p by targeting CCND1\/CDK6[J]. Onco Targets Ther. 11, 6081\u20136090 (2018).","journal-title":"Onco Targets Ther."},{"issue":"3","key":"54166_CR31","first-page":"1997","volume":"19","author":"YJ Guo","year":"2020","unstructured":"Guo, Y. J. et al. ERK\/MAPK signalling pathway and tumorigenesis[J]. Exp. Ther. Med. 19 (3), 1997\u20132007 (2020).","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"54166_CR32","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3390\/cells9010198","volume":"9","author":"U Degirmenci","year":"2020","unstructured":"Degirmenci, U., Wang, M. & Hu, J. Targeting Aberrant RAS\/RAF\/MEK\/ERK Signaling for Cancer Therapy[J]. Cells 9 (1), 198 (2020).","journal-title":"Cells"},{"issue":"7498","key":"54166_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature13176","volume":"509","author":"Y Song","year":"2014","unstructured":"Song, Y. et al. Identification of genomic alterations in oesophageal squamous cell cancer[J]. Nature 509 (7498), 91\u201395 (2014).","journal-title":"Nature"},{"issue":"3","key":"54166_CR34","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1158\/2159-8290.CD-18-1321","volume":"9","author":"R Yaeger","year":"2019","unstructured":"Yaeger, R. & Corcoran, R. B. Targeting Alterations in the RAF-MEK Pathway[J]. Cancer Discov. 9 (3), 329\u2013341 (2019).","journal-title":"Cancer Discov"},{"issue":"36","key":"54166_CR35","doi-asserted-by":"publisher","first-page":"e1246","DOI":"10.1097\/MD.0000000000001246","volume":"94","author":"Y Gao","year":"2015","unstructured":"Gao, Y., Chen, F., Niu, S., Lin, S. & Li, S. Replication and Meta-Analysis of Common Gene Mutations in TTF1 and TTF2 with Papillary Thyroid Cancer[J]. Med. (Baltim). 94 (36), e1246 (2015).","journal-title":"Med. (Baltim)."},{"key":"54166_CR36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.lungcan.2017.03.015","volume":"108","author":"JB Schilsky","year":"2017","unstructured":"Schilsky, J. B. et al. Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas[J]. Lung Cancer. 108, 205\u2013211 (2017).","journal-title":"Lung Cancer"},{"issue":"4","key":"54166_CR37","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.bbrc.2018.10.015","volume":"505","author":"M ZAMBONI","year":"2018","unstructured":"ZAMBONI, M. TTF-1 \/ Nkx2. 1 functional connection with mutated EGFR relies on LRIG1 and \u03b2-catenin pathways in lung cancer cells[J]. Biochem. Biophys. Res. Commun. 505 (4), 1027\u20131031 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"54166_CR38","doi-asserted-by":"publisher","first-page":"100915","DOI":"10.1016\/j.drup.2022.100915","volume":"67","author":"Z Yu","year":"2023","unstructured":"Yu, Z. et al. Exosomal LOC85009 inhibits docetaxel resistance in lung adenocarcinoma through regulating ATG5-induced autophagy[J]. Drug Resist. Updat. 67, 100915 (2023).","journal-title":"Drug Resist. Updat"},{"issue":"5","key":"54166_CR39","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.32604\/or.2024.058256","volume":"33","author":"J Wang","year":"2025","unstructured":"Wang, J., Ge, H., Yu, Z. & Wu, L. Non-coding RNAs as potential mediators of resistance to lung cancer immunotherapy and chemotherapy[J]. Oncol. Res. 33 (5), 1033\u20131054 (2025).","journal-title":"Oncol. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54166-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54166-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54166-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T04:01:31Z","timestamp":1785038491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54166-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["54166"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-54166-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All studies involving human tissues were conducted in strict accordance with the Declaration of Helsinki and were approved by the Ethics Committee of the affiliated Hospital of Chengde Medical University. The clinical information of esophageal cancer patients comes from the public database and does not involve ethical issues. The experimental research program has been approved by the Ethics Committee of the affiliated Hospital of Chengde Medical University, and written informed consent was obtained from the patients. The ethical approval number is CYFYLL2023675.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23060"}}